Genome Canada Appoints Wellcome Trust Giant, Pre-Eminent UK Scientist And Researcher: Dr. Michael Morgan, Accepts Genome Canada Chief Scientific Officer's Post

OTTAWA, ONTARIO--(CCNMatthews - June 14, 2006) - Genome Canada is pleased to announce the appointment of Dr. Michael Morgan as its new Chief Scientific Officer (CSO). In his new role, which began June 1, 2006, Dr. Morgan - UK's internationally-renowned researcher and former Chief Executive of the Wellcome Trust Genome Campus - will assure Canada's continued prominence in the genomics and proteomics research field.